Literature DB >> 15770047

Leptin levels in obese women with and without type 2 diabetes mellitus.

Mehmet Akif Buyukbese1, Ali Cetinkaya, Ramazan Kocabas, Aytekin Guven, Mehmet Tarakcioglu.   

Abstract

INTRODUCTION: The role of leptin has been more clear in the endocrinology area after the discovery of its secretion from the adipose tissue. The aim of the study is to investigate the leptin levels in obese women in whom type 2 diabetes mellitus were present or absent.
MATERIALS AND METHODS: Thirty-five obese women with type 2 diabetes mellitus (group 1) and 34 obese women without type 2 diabetes mellitus (group 2) were enrolled in the study. In both groups the body mass index (BMI), waist circumference, and waist-to-hip ratio were measured. Leptin, HbA1c, creatinine and the lipid profile were assessed.
RESULTS: Leptin was found to be statistically significantly lower in group 1 than in group 2 (40.22 +/- 17.77 ng/ml versus 50.12 +/- 15.51 ng/ml, respectively; p = 0.019). It was well correlated with BMI in group 1 (r = 0.60, p = 0.0001). In group 1 also, correlation of leptin was moderate with creatinine and high-density lipoprotein-cholesterol (r = 0.36, p = 0.037 versus r = 0.37, p = 0.027, respectively), whereas triglyceride had a negative correlation (r = -0.34, p = 0.046). In group 2, the only significant correlation with leptin was BMI (r = 0.41, p = 0.02). Leptin was also significantly lower in 17 subjects with poorly controlled diabetes mellitus than in 18 well-controlled diabetics (33.54 +/- 15.82 ng/ml versus 44.61 +/- 17.54 ng/ml, respectively; p = 0.038).
CONCLUSION: Since leptin is lower in obese women with diabetes than without diabetes and additionally it is even lower in the poorly controlled diabetes subgroup, we think that further studies a rerequired to make clear the issue for lower leptin levels, whether it is a reason or an outcome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15770047      PMCID: PMC1781572          DOI: 10.1080/09629350400008828

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  42 in total

1.  Association of poorly controlled diabetes with low serum leptin in morbid obesity.

Authors:  K Clément; N Lahlou; J Ruiz; J Hager; P Bougnères; A Basdevant; B Guy-Grand; P Froguel
Journal:  Int J Obes Relat Metab Disord       Date:  1997-07

2.  Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men.

Authors:  F Jockenhövel; W F Blum; E Vogel; P Englaro; D Müller-Wieland; D Reinwein; W Rascher; W Krone
Journal:  J Clin Endocrinol Metab       Date:  1997-08       Impact factor: 5.958

3.  Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action.

Authors:  L Rossetti; D Massillon; N Barzilai; P Vuguin; W Chen; M Hawkins; J Wu; J Wang
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

4.  Correlates of leptin concentration in the San Antonio Heart Study.

Authors:  T R Nagy; B A Gower
Journal:  Ann Epidemiol       Date:  1997-02       Impact factor: 3.797

5.  Gender differences in serum leptin in obese people: relationships with testosterone, body fat distribution and insulin sensitivity.

Authors:  R Vettor; G De Pergola; C Pagano; P Englaro; E Laudadio; F Giorgino; W F Blum; R Giorgino; G Federspil
Journal:  Eur J Clin Invest       Date:  1997-12       Impact factor: 4.686

6.  Human plasma leptin in obese subjects and diabetics.

Authors:  Y Tasaka; K Yanagisawa; Y Iwamoto
Journal:  Endocr J       Date:  1997-10       Impact factor: 2.349

7.  Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells.

Authors:  T J Kieffer; R S Heller; C A Leech; G G Holz; J F Habener
Journal:  Diabetes       Date:  1997-06       Impact factor: 9.461

8.  Hyperleptinaemia: the missing link in the, metabolic syndrome?

Authors:  M de Courten; P Zimmet; A Hodge; V Collins; M Nicolson; M Staten; G Dowse; K G Alberti
Journal:  Diabet Med       Date:  1997-03       Impact factor: 4.359

Review 9.  [Obesity and inflammation: the adipocytokines].

Authors:  H Vidal
Journal:  Ann Endocrinol (Paris)       Date:  2003-11       Impact factor: 2.478

10.  Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action.

Authors:  R C Frederich; A Hamann; S Anderson; B Löllmann; B B Lowell; J S Flier
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

View more
  4 in total

1.  Curcumin protects hepatic stellate cells against leptin-induced activation in vitro by accumulating intracellular lipids.

Authors:  Youcai Tang; Anping Chen
Journal:  Endocrinology       Date:  2010-07-21       Impact factor: 4.736

2.  Serum leptin level is reduced in non-obese subjects with type 2 diabetes.

Authors:  Ghorban Mohammadzadeh; Nosratollah Zarghami
Journal:  Int J Endocrinol Metab       Date:  2012-12-21

3.  Low serum cartonectin/CTRP3 concentrations in newly diagnosed type 2 diabetes mellitus: in vivo regulation of cartonectin by glucose.

Authors:  Bo Ban; Bo Bai; Manman Zhang; Jiamiao Hu; Manjunath Ramanjaneya; Bee K Tan; Jing Chen
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

4.  Leptin is an independent marker of metabolic syndrome in elderly adults with type 2 diabetes.

Authors:  Pei-Wei Tseng; Du-An Wu; Jia-Sian Hou; Bang-Gee Hsu
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2017 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.